News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
783,912 Results
Type
Article (76077)
Company Profile (735)
Press Release (707100)
Section
Business (221903)
Career Advice (3061)
Deals (37781)
Drug Delivery (113)
Drug Development (87930)
Employer Resources (174)
FDA (17361)
Job Trends (16716)
News (376444)
Policy (36511)
Tag
Academia (2970)
Alliances (54865)
Alzheimer's disease (1331)
Approvals (17266)
Artificial intelligence (147)
Bankruptcy (352)
Best Places to Work (12495)
Biotechnology (504)
Breast cancer (125)
Cancer (1115)
Career advice (2567)
Cell therapy (252)
Clinical research (69170)
Collaboration (395)
Compensation (192)
COVID-19 (2772)
C-suite (98)
Data (1071)
Diabetes (162)
Diagnostics (6638)
Drug pricing (99)
Earnings (88611)
Employer resources (152)
Events (122856)
Executive appointments (295)
FDA (17886)
Funding (350)
Gene therapy (189)
GLP-1 (683)
Government (4869)
Healthcare (20639)
Infectious disease (2861)
Inflammatory bowel disease (118)
Interviews (551)
IPO (17197)
Job creations (4648)
Job search strategy (2191)
Layoffs (473)
Legal (8844)
Lung cancer (182)
Manufacturing (193)
Medical device (14299)
Medtech (14304)
Mergers & acquisitions (20652)
Metabolic disorders (454)
Neuroscience (1617)
NextGen Class of 2024 (7551)
Non-profit (5046)
Northern California (1452)
Obesity (261)
Opinion (240)
Patents (107)
People (62085)
Pharmaceutical (147)
Phase I (21365)
Phase II (30119)
Phase III (22724)
Pipeline (451)
Postmarket research (3256)
Preclinical (9668)
Radiopharmaceuticals (256)
Rare diseases (230)
Real estate (7064)
Regulatory (24186)
Research institute (2635)
Resumes & cover letters (470)
Southern California (1304)
Startups (4063)
United States (14082)
Vaccines (632)
Weight loss (214)
Date
Last 7 days (954)
Last 30 days (3639)
Last 365 days (38072)
2024 (34528)
2023 (42485)
2022 (53866)
2021 (58636)
2020 (57544)
2019 (51182)
2018 (38914)
2017 (36049)
2016 (36485)
2015 (42690)
2014 (37184)
2013 (34396)
2012 (34877)
2011 (34906)
2010 (34258)
Location
Africa (1098)
Arizona (192)
Asia (46843)
Australia (8235)
California (3388)
Canada (1274)
China (246)
Colorado (153)
Connecticut (162)
Europe (106588)
Florida (452)
Georgia (123)
Illinois (397)
Indiana (210)
Kansas (103)
Maryland (620)
Massachusetts (2768)
Michigan (170)
Minnesota (292)
New Jersey (972)
New York (968)
North Carolina (825)
Northern California (1452)
Ohio (143)
Pennsylvania (840)
South America (1443)
Southern California (1304)
Texas (481)
Washington State (392)
783,912 Results for "purdue pharma l p research and development new jersey".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Purdue Pharma L.P. Awards Grant for Investigator-initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. (“Purdue”) announced today that the Company has awarded an investigator-initiated research (IIR) grant to a team of researchers at The University of New Mexico (UNM) for the evaluation of nalmefene hydrochloride (HCl) injection 2mg/2mL (1mg/1mL) in the emergency department setting.
March 27, 2024
·
7 min read
Press Releases
Boehringer Ingelheim and Circle Pharma Announce New Research Collaboration to Develop a Novel Precision Cancer Treatment
October 9, 2024
·
4 min read
Press Releases
Mitsubishi Tanabe Pharma America Unveils New ALS Research Findings at NEALS 2024 Annual Meeting
October 18, 2024
·
10 min read
Pharm Country
FDA Accepts Filing of New Drug Application for Nalmefene Auto-injector for the Treatment of Known or Suspected Opioid Overdose
Purdue Pharma L.P. (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector delivery form of nalmefene hydrochloride injection*.
April 8, 2024
·
6 min read
ProBio Expands Plasmid DNA and Viral Vector Production in New Jersey to Accelerate Delivery of Life-Changing Cell and Gene Therapies
ProBio Inc, a New Jersey-based contract development and manufacturing organization (CDMO), proudly announce the expansion of its plasmid DNA and viral vector manufacturing capabilities with the opening of a new state-of-the-art facility in Hopewell, New Jersey.
June 25, 2024
·
2 min read
Pharm Country
Purdue Pharma L.P. to Provide Funding Opportunities for Investigator-Initiated Research to Examine Opioid Overdose Reversal Using Nalmefene HCl Injection
Purdue Pharma L.P. is accepting proposals for investigator-initiated research (IIR) to examine the outcomes associated with the use of Nalmefene Hydrochloride injection, 2mg/2mL (1mg/1mL).
March 28, 2023
·
6 min read
Drug pricing
NJ Court Tosses Novartis’ Lawsuit Against Drug Negotiation Program in Latest Setback for Big Pharma
With Friday’s ruling by New Jersey District Judge Zahid Quraishi, Novartis joins a growing list of pharmaceutical companies that have failed in their legal challenges to the Inflation Reduction Act.
October 21, 2024
·
2 min read
·
Tristan Manalac
Business
Empower Pharma to Purchase Eugia Manufacturing Facility in New Jersey for Large Scale Expansion of Personalized Compounded Medicine
Empower Clinic Services New Jersey LLC DBA Empower Pharma announced an agreement to purchase a facility in East Windsor, New Jersey from Eugia US Manufacturing LLC and enter into a contract manufacturing relationship.
February 5, 2024
·
3 min read
Press Releases
Inozyme Pharma Presents New Data at the American Society for Bone and Mineral Research (ASBMR) 2024 Annual Meeting
September 27, 2024
·
11 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
1 of 78,392
Next
